Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Structure of the minimal type I-F2 CRISPR-Cas DNA-interference complex

ABSTRACT: CRISPR–Cas systems provide adaptive immunity in prokaryotes by targeting and degrading invasive genetic elements. Among them, the type I-F2 system represents the most compact type I CRISPR–Cas system, distinguished by the absence of small and large subunits. These subunits are otherwise essential for target recognition and nuclease recruitment. To elucidate how this minimal system mediates DNA interference, we determined the cryo-electron microscopy (cryo-EM) structure of the I-F2 Cascade complex bound to its target DNA and the effector helicase-nuclease Cas3. Our structure reveals a unique mechanism of Cas3 recruitment, predominantly mediated by the Cas7 subunit. We show how the helicase and C-terminal domains of Cas3 engage the single-stranded DNA to initiate directional DNA-unwinding and degradation. These findings uncover key mechanistic adaptations that enable efficient interference in the absence of canonical subunits and emphasize the mechanistic diversity among closely related type I systems, including I-E, I-F1, and I-F2. These insights provide a structural basis for engineering the minimal I-F2 system for genome editing and biotechnological applications.

INSTRUMENT(S):

ORGANISM(S): Shewanella Putrefaciens Cn-32

SUBMITTER: Wieland Steinchen

LAB HEAD: Gert Bange

PROVIDER: PXD068253 | Pride | 2026-03-09

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	171114_HX_075_Ba_Cas3.DnX	Other
	171114_HX_075_Ba_Cas3.fas	Other
	171114_HX_075_Ba_Cascade.DnX	Other
	171114_HX_075_Ba_Cascade.fas	Other
	171114_HX_075_Ba_PLGS_Cas3.zip	Other

Items per page:

1 - 5 of 12

Similar Datasets

Pausing protein acetylation by an Ac-CoA synthetase/acetyltransferase complex.

Project description:Acetyl-CoA synthetase (Acs) generates acetyl-Coenzyme A (Ac-CoA) but its excessive activity can deplete ATP and lead to growth arrest. To prevent this, Acs is tightly regulated through Ac-CoA-dependent feedback inhibition executed by Ac-CoA-dependent acetyltransferases such as AcuA in Bacillus subtilis. AcuA acetylates the catalytic lysine of AcsA turning the synthetase inactive. Here we report an Ac-CoA independent inhibition mechanism of AcsA, which relies on a complex between AcsA and AcuA. Our structural analysis reveals that AcuA and AcsA form a tightly intertwined complex – the C-terminal domain binds to acetyltransferase domain of AcuA, while the C-terminus of AcuA occupies the CoA-binding site in the N-terminal domain of AcsA. Our structure-guided biochemical analysis reveals that AcuA inhibits AcsA by an Ac-CoA-independent inhibition via the AcsA-AcuA complex, in addition to the well-known Ac-CoA-dependent inhibition via acetylation of the catalytic lysine 549 in AcsA disrupting the complex. These findings elucidate how AcuA specifically binds to its target and inhibits activity through an unprecedented Ac-CoA-independent mechanism when Ac-CoA levels are low. Our study suggests that the two mechanistically distinct inhibitory mechanisms accomplished by AcuA adjust AcsA activity to the cellular concentrations of the different substrates of the reaction, illustrating the complexity underlying the regulatory framework of acetyl-CoA synthesis from acetate.

2025-02-28 | PXD058390 | Pride

A protein adaptor mediating Ap4A-dependent control of protein acetylation.

Project description:Reversible lysine acetylation is a highly conserved post-translational modification across all domains of life, modulating diverse cellular processes. However, the regulatory mechanisms governing this modification remain poorly understood. Here, we uncover a novel regulatory system in Bacillus subtilis involving the histone deacetylase (HDAC)-like protein AcuC, which targets multiple substrates, including acetyl-CoA synthetase and translation elongation factor. We show that AcuC is inhibited through complex formation with AcuB, a previously uncharacterized protein. We further demonstrate that the alarmone diadenosine tetraphosphate (Ap4A) binds to the cystathionine beta-synthase (CBS) domain of AcuB, stabilizing the AcuB-AcuC complex and enhancing AcuC inhibition. This study identify AcuB as an Ap4A-enhanced deacetylation inhibitor, revealing a new regulatory mechanism for HDAC-like proteins. Our findings also provide the first direct evidence that the secondary messenger Ap4A modulates protein (de)acetylation, highlighting a regulatory network linking cell stress, proteome acetylation, and acetyl-CoA availability. These insights advance our understanding of protein acetylation control.

2026-01-21 | PXD064203 | Pride

A Leishmania virulence factor harnesses an allosteric kinase switch to regulate its ubiquitin ligase activity

Project description:Stringent control of ubiquitylation is a central requirement of signaling specificity in eukaryotes. Here, we discover a domain module integrating protein kinase and ubiquitin ligase domains within a single protein. This module is widespread across unicellular eukaryotic lineages and particularly conserved in Leishmania, the causative agents of major neglected tropical diseases with a strong therapeutic need. We reveal that a gene encoding the module, TKUL, is essential for L. mexicana to sustain macrophage infections and that TKUL can cooperate with HSP70 to modify unfolded proteins with degradative ubiquitin chains. Intriguingly, the HECT-type ubiquitin ligase activity of TKUL requires its atypical kinase domain, with kinase autophosphorylation triggering activating conformational changes across the catalytic module. Consistent with the ligase domain harnessing the kinase domain for regulation, TKUL-driven ubiquitylation can allosterically be suppressed by small-molecule kinase inhibitors. Together, this work establishes an unprecedented allosteric coupling mechanism in the realms of phosphorylation and ubiquitylation.

2025-09-23 | PXD057190 | Pride

Mechanism of cooperative strigolactone perception by the MAX2 ubiquitin ligase–receptor–substrate complex

Project description:Strigolactones are plant hormones that regulate development and mediate interactions with soil organisms, including the germination of parasitic plants such as Striga hermonthica. Strigolactone perception by receptors initiates the degradation of transcriptional repressors via E3 ubiquitin ligases, but the mechanistic link between hormone binding and substrate ubiquitination has remained unclear. We determined cryogenic electron microscopy structures of the receptor–ligase–substrate complex, composed of Arabidopsis ASK1 and substrate, and Striga F-box and receptor proteins. Strigolactone hydrolysis by the receptor, which covalently retains the D-ring, is a prerequisite for complex formation. The substrate engages the complex through two domains, forming a dynamic interface that stabilises the receptor–ligase assembly and repositions the ASK1, suggesting a mechanism for efficient ubiquitination. Here, we show how dynamic, multivalent interactions within the receptor–ligase–substrate complex translate hormone perception into targeted protein degradation, providing insight into how plants integrate hormonal signals into developmental decisions.

2025-09-19 | PXD068313 | Pride

Ancestral sequence reconstruction reveals CTP-dependent parS binding as an ancient feature of ParB DNA segregation proteins

Project description:In most bacteria, chromosome and low-copy plasmid segregation are mediated by the ParABS system. Its component ParB functions as a DNA sliding clamp that assembles on centromere-like parS sites to form large nucleoprotein complexes, which are subsequently positioned by the ATPase ParA. Loading of ParB onto DNA is regulated by a recently discovered, conserved CTPase domain, yet the evolutionary origin of this regulatory module remains unclear. Here, we apply ancestral sequence reconstruction to resurrect anci¬ent ParB proteins dating back to the last common ancestor of bacteria. Biochemical, structural, and cell biological analyses demonstrate that these reconstructed proteins display all core activities of their mod¬ern counterparts, suggesting that the ParABS system emerged early during bacterial evolution and has essentially re¬mained unchanged ever since. More broadly, our findings indicate that regulatory CTP¬ases repre¬sent an ancient molecular innovation, whose origins can be traced back to the earliest stages of life.

2026-01-07 | PXD069026 | Pride

Retron Eco2 breaks tRNAs for anti-phage defense

Project description:Retrons mediate bacterial anti-phage defense by reverse transcribing non-coding RNA into multicopy single-stranded DNA (msDNA). Our study reveals the unique trimeric nucleoprotein structure of Eco2, which solely relies on a single protein for defense, unlike most other retrons. This structure supports an msDNA-dependent regulation of the Eco2's reverse-transcriptase and TOPRIM/RNase H (TR) fusion protein. We also show that Eco2's broad defense against various phages is triggered by a phage-encoded endonuclease that degrades the msDNA. msDNA decay in turn activates the TR domain for tRNA cleavage, resulting in shutdown of gene expression for abortive infection. Our findings not only advance the understanding of Eco2’s biogenesis and defense mechanism but also provide a structural basis for engineering of this system.

2026-02-03 | PXD060313 | Pride

Structural mechanisms of autoinhibition and substrate recognition by the ubiquitin ligase HACE1

Project description:Ubiquitin ligases (E3s) are pivotal specificity determinants in the ubiquitin system by selecting substrates and decorating them with distinct ubiquitin signals. Structure determination of the underlying, specific E3-substrate complexes, however, has proven challenging due to their transient nature. In particular, it is incompletely understood how members of the catalytic cysteine-driven class of HECT-type ligases position substrate proteins for modification. Here we report a cryo-EM structure of the full-length human HECT-type ligase HACE1, along with solution-based conformational analyses by small-angle X-ray scattering and hydrogen-deuterium exchange mass spectrometry. Structure-based functional analyses in vitro and in cells reveal that the activity of HACE1 is stringently regulated by dimerization-induced autoinhibition. The inhibition occurs at the first step of the catalytic cycle and is thus substrate-independent. We employ mechanism-based chemical crosslinking to reconstitute a complex of activated, monomeric HACE1 with its major substrate, RAC1, visualize its structure by cryo-EM, and validate the binding mode by solution-based analyses. Our findings explain how HACE1 achieves selectivity in ubiquitinating the active, GTP-loaded state of RAC1 and establish a framework for interpreting mutational alterations of the HACE1-RAC1 interplay in disease. More broadly, this work illuminates central unexplored aspects in the architecture, conformational dynamics, regulation, and specificity of full-length HECT-type ligases.

2024-02-12 | PXD045837 | Pride

Selective ubiquitination of drug-like small molecules by the ubiquitin ligase HUWE1

Project description:The ubiquitin system regulates eukaryotic physiology by modifying specific substrate proteins. Substrate recruitment and the assembly of ubiquitin signals are determined by ubiquitin ligases, some of which also modify non-protein biomolecules. Here we expand this substrate realm, revealing that the human ubiquitin ligase HUWE1 can target drug-like small molecules. We demonstrate that compounds previously reported as HUWE1 inhibitors present substrates of their target ligase. Compound ubiquitination is driven by the canonical catalytic cascade, linking ubiquitin to the compound’s primary amino group. In vitro, the modification is selectively catalyzed by HUWE1, allowing the compounds to compete with protein substrates. We establish cellular detection methods, confirming HUWE1 promotes – but does not exclusively drive – compound ubiquitination in cells. Converting the existing compounds into specific HUWE1 substrates or inhibitors thus requires enhanced specificity. More broadly, our findings open avenues for harnessing the ubiquitin system to convert exogenous small molecules into novel chemical modalities within cells.

2025-09-02 | PXD066563 | Pride

HDX-MS finds that partial unfolding with sequential domain activation controls condensation of a cellular stress marker

Project description:Poly(A)-binding protein (Pab1), a canonical stress granule marker, condenses upon heat shock or starvation, promoting adaptation, The molecular basis of condensation has remained elusive due to a dearth of techniques to probe structure directly in condensates. Here we apply hydrogendeuterium exchange/mass spectrometry (HDX-MS) to investigate the molecular mechanism of Pab1’s condensation. We find that Pab1’s four RNA recognition motifs (RRMs) undergo different levels of partial unfolding upon condensation, and the changes are similar for thermal and pH stresses. Although structural heterogeneity is observed, the ability of MS to describe individual subpopulations allows us to identify which regions become partially unfolded and contribute to the condensate’s interaction network. Our data yield a clear molecular picture of Pab1’s stresstriggered condensation, which we term sequential activation, wherein each RRM becomes activated at a temperature where it partially unfolds and associates with other likewise activated RRMs to form the condensate. This model thus implies that sequential activation is dictated by the underlying free energy surface, an effect we refer to as thermodynamic specificity. Our study represents a methodological advance for elucidating the interactions that drive biomolecular condensation that we anticipate will be widely applicable. Furthermore, our findings demonstrate how condensation can use thermodynamic specificity to perform an acute response to multiple stresses, a potentially general mechanism for stress-responsive proteins.

2024-03-22 | PXD049463 | Pride

Structure–Function Relationships and Therapeutic Potential of Non-Covalent PPARγ Inverse Agonists

Project description:Peroxisome proliferator-activated receptor gamma (PPARγ) is a validated therapeutic target for type 2 diabetes (T2D), but current FDA-approved agonists such as the glitazones are limited by adverse effects. SR10171, a non-covalent partial inverse agonist with modest binding potency, improves insulin sensitivity in mice without bone loss or marrow adiposity. Here, we characterize a series of SR10171 analogs to define structure-function relationships using biochemical assays, hydrogen-deuterium exchange (HDX), and computational modeling. Analogs featuring flipped indole scaffolds with alkyl substitutions exhibited 10-100-fold enhanced binding to PPARγ while retaining inverse agonist activity. HDX and molecular dynamic simulations revealed that ligand-induced dynamics within ligand-binding pocket and AF2 domain correlate with enhanced receptor binding. Lead analogs restored receptor activity in loss-of-function PPAR variants and improved insulin sensitivity in adipocytes from a diabetic patient. These findings provide mechanistic insights into non-covalent PPARγ modulation establishing a framework for developing safer, next-generation insulin sensitizers for metabolic disease therapy.

2025-11-15 | PXD066095 | Pride